Alerts

Brauer Natural Medicine is recalling several batches of its Baby & Child Teething Gel, 20 g, due to the potential for a small plastic fragment from the tube rim being present in the gel.

Ritalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.

Acne medication warnings further highlight potential risks of mood-related changes and sexual disorders.

We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.

Takeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.

Magnum XXL capsules pose a serious risk to your health and should not be taken.

Several vitamin and perinatal (including preconception) products are being recalled due to a lack of or excessive levels of potassium iodine.

Reynard Health Supplies is conducting a Critical Recall of the above products. A contamination problem has been identified with the products.

More prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.

Possible risk of learning, communication and behaviour problems in children born to men taking this medicine.

Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes